
The Testosterone Tipping Point: TRT Use Surges Amid Telehealth Boom
A surge in testosterone replacement therapy (TRT) driven by the telehealth boom is making it easier for men to obtain high-dose regimens, often with limited cardiovascular screening. Doctors warn that many patients seek elevated levels rather than treating deficiencies, raising risks such as thickened blood, mood changes, and fertility issues. While FDA advisers consider loosening restrictions to improve access for those with low testosterone, experts caution against abuse and stress that TRT is not a magic pill—set against a backdrop of declining average testosterone and broader public‑health concerns about safety and monitoring.








